Rate My Professor Bente Talseth-Palmer

Her research focuses on medical genetics, specializing in genetic modifiers of disease risk in Lynch syndrome (hereditary non-polyposis colorectal cancer), inherited colorectal cancer genomics, single nucleotide polymorphisms, genome-wide SNP array technology, and acute lymphoblastic leukaemia. She has secured over $2.2 million in grant funding as lead investigator, including projects on genetic factors in inherited colon cancer ($454,798, 2013) and Lynch syndrome modifiers ($500,000, 2017). Notable publications include 'Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing' (BMC Medical Genomics, 2023), 'MTHFR C677T and A1298C polymorphism’s effect on risk of colorectal cancer in Lynch syndrome' (Scientific Reports, 2023), 'Exome sequencing of familial adenomatous polyposis-like individuals identifies both known and novel causative genes' (Clinical Genetics, 2021), 'The genetic basis of colonic adenomatous polyposis syndromes' (Hereditary Cancer in Clinical Practice, 2017), and 'MSH6 and PMS2 mutation positive Australian Lynch syndrome families' (Clinical Genetics, 2010). With approximately 1,400 citations, her contributions extend to international collaborations, such as HNPCC studies with Leiden University Medical Center (Netherlands), MOMA with MRC (UK), and modifier genes research with Karolinska Institute (Sweden) and Poland's International Hereditary Cancer Center. Awards include the Hunter Medical Research Institute Pulse Education Prize (2009), Cancer Institute NSW Research Scholar Award (2005), and multiple travel grants. She supervises honours and PhD students, reviews for Cancer Causes & Control, and has contributed chapters like 'The Role of Modifier Genes in Lynch Syndrome' (2012).